Literature DB >> 26096665

Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment.

Zahinoor Ismail1, Eric E Smith2, Yonas Geda3, David Sultzer4, Henry Brodaty5, Gwenn Smith6, Luis Agüera-Ortiz7, Rob Sweet8, David Miller9, Constantine G Lyketsos10.   

Abstract

Neuropsychiatric symptoms (NPS) are common in dementia and in predementia syndromes such as mild cognitive impairment (MCI). NPS in MCI confer a greater risk for conversion to dementia in comparison to MCI patients without NPS. NPS in older adults with normal cognition also confers a greater risk of cognitive decline in comparison to older adults without NPS. Mild behavioral impairment (MBI) has been proposed as a diagnostic construct aimed to identify patients with an increased risk of developing dementia, but who may or may not have cognitive symptoms. We propose criteria that include MCI in the MBI framework, in contrast to prior definitions of MBI. Although MBI and MCI can co-occur, we suggest that they are different and that both portend a higher risk of dementia. These MBI criteria extend the previous literature in this area and will serve as a template for validation of the MBI construct from epidemiologic, neurobiological, treatment, and prevention perspectives.
Copyright © 2016 The Alzheimer's Association. All rights reserved.

Entities:  

Keywords:  Agitation; Alzheimer's disease; Apathy; BPSD; Behavior; Behaviour; Dementia; Depression; Disinhibition; FTD; MBI; MCI; NPS; Neuropsychiatric symptoms of dementia; Psychosis

Mesh:

Year:  2015        PMID: 26096665      PMCID: PMC4684483          DOI: 10.1016/j.jalz.2015.05.017

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  47 in total

1.  Apathy and cortical atrophy in Alzheimer's disease.

Authors:  C Tunnard; D Whitehead; C Hurt; L O Wahlund; P Mecocci; M Tsolaki; B Vellas; C Spenger; I Kłoszewska; H Soininen; S Lovestone; A Simmons
Journal:  Int J Geriatr Psychiatry       Date:  2010-09-27       Impact factor: 3.485

2.  Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia.

Authors:  Frédéric Peters; Daniela Perani; Karl Herholz; Vjera Holthoff; Bettina Beuthien-Baumann; Sandro Sorbi; Alberto Pupi; Christian Degueldre; Christian Lemaire; Fabienne Collette; Eric Salmon
Journal:  Dement Geriatr Cogn Disord       Date:  2006-03-07       Impact factor: 2.959

3.  A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia.

Authors:  Zahinoor Ismail; Chetachi A Emeremni; Patricia R Houck; Sati Mazumdar; Jules Rosen; Tarek K Rajji; Bruce G Pollock; Benoit H Mulsant
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-02       Impact factor: 4.105

4.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

Authors:  Paul B Rosenberg; Michelle M Mielke; Brian S Appleby; Esther S Oh; Yonas E Geda; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

5.  Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study.

Authors:  M E Peters; P B Rosenberg; M Steinberg; M C Norton; K A Welsh-Bohmer; K M Hayden; J Breitner; J T Tschanz; C G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

6.  The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.

Authors:  Kate de Medeiros; P Robert; S Gauthier; F Stella; A Politis; J Leoutsakos; F Taragano; J Kremer; A Brugnolo; A P Porsteinsson; Y E Geda; H Brodaty; G Gazdag; J Cummings; C Lyketsos
Journal:  Int Psychogeriatr       Date:  2010-07-01       Impact factor: 3.878

7.  Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease.

Authors:  Kristiina Karttunen; Pertti Karppi; Asta Hiltunen; Matti Vanhanen; Tarja Välimäki; Janne Martikainen; Hannu Valtonen; Juhani Sivenius; Hilkka Soininen; Sirpa Hartikainen; Jaana Suhonen; Tuula Pirttilä
Journal:  Int J Geriatr Psychiatry       Date:  2010-10-29       Impact factor: 3.485

8.  Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease.

Authors:  S Tekin; M S Mega; D M Masterman; T Chow; J Garakian; H V Vinters; J L Cummings
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

Review 9.  The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.

Authors:  J L Cummings
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

10.  Fronto-temporal dementia presenting as Geschwind's syndrome.

Authors:  Alfredo Postiglione; Graziella Milan; Sabina Pappatà; Caterina De Falco; Francesco Lamenza; Vincenzo Schiattarella; Giovanni Gallotta; Paolo Sorrentino; Salvatore Striano
Journal:  Neurocase       Date:  2008       Impact factor: 0.881

View more
  145 in total

Review 1.  A practical approach to detection and treatment of depression in Parkinson disease and dementia.

Authors:  Zahra Goodarzi; Zahinoor Ismail
Journal:  Neurol Clin Pract       Date:  2017-04

Review 2.  The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.

Authors:  David S Knopman; Samantha Budd Haeberlein; Maria C Carrillo; James A Hendrix; Geoff Kerchner; Richard Margolin; Paul Maruff; David S Miller; Gary Tong; Maria B Tome; Melissa E Murray; Peter T Nelson; Mary Sano; Niklas Mattsson; David L Sultzer; Thomas J Montine; Clifford R Jack; Hartmuth Kolb; Ronald C Petersen; Prashanthi Vemuri; Megan Zoschg Canniere; Julie A Schneider; Susan M Resnick; Gary Romano; Argonde Corien van Harten; David A Wolk; Lisa J Bain; Eric Siemers
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

3.  State of the Science: Apathy As a Model for Investigating Behavioral and Psychological Symptoms in Dementia.

Authors:  Lauren Massimo; Helen C Kales; Ann Kolanowski
Journal:  J Am Geriatr Soc       Date:  2018-04       Impact factor: 5.562

4.  Apathy and Disinhibition Related to Neuropathology in Amnestic Versus Behavioral Dementias.

Authors:  Letizia G Borges; Alfred W Rademaker; Eileen H Bigio; M-Marsel Mesulam; Sandra Weintraub
Journal:  Am J Alzheimers Dis Other Demen       Date:  2019-06-06       Impact factor: 2.035

5.  Detecting and Managing Neuropsychiatric Symptoms in Dementia.

Authors:  Andrea Iaboni; Mark J Rapoport
Journal:  Can J Psychiatry       Date:  2017-03       Impact factor: 4.356

6.  White matter involvement in young non-demented Down's syndrome subjects: a tract-based spatial statistic analysis.

Authors:  Andrea Romano; Marta Moraschi; Riccardo Cornia; Alessandro Bozzao; Maria Camilla Rossi-Espagnet; Federico Giove; Giorgio Albertini; Alberto Pierallini
Journal:  Neuroradiology       Date:  2018-09-27       Impact factor: 2.804

7.  Symptom Clusters of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Comparative Risks of Dementia: A Cohort Study of 8530 Older Persons.

Authors:  Tau Ming Liew
Journal:  J Am Med Dir Assoc       Date:  2019-03-26       Impact factor: 4.669

8.  Anxiety and Depression as Longitudinal Predictors of Mild Cognitive Impairment in Older Adults.

Authors:  Antônio Carlos Cruz Freire; Milena Pereira Pondé; Aihua Liu; Jean Caron
Journal:  Can J Psychiatry       Date:  2017-03-27       Impact factor: 4.356

9.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Psychosis in "Cognitively Asymptomatic" Elderly Subjects is Associated With Neuritic Plaque Load, Not Neurofibrillary Tangles.

Authors:  Julia Kim; Tom A Schweizer; Corinne E Fischer; David G Munoz
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Jul-Sep       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.